Citigroup Inc. Raises Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Citigroup Inc. increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 20.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 351,529 shares of the real estate investment trust’s stock after buying an additional 58,950 shares during the quarter. Citigroup Inc.’s holdings in Omega Healthcare Investors were worth $14,307,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. boosted its holdings in shares of Omega Healthcare Investors by 6.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock worth $155,893,000 after buying an additional 240,006 shares during the last quarter. Smithfield Trust Co lifted its holdings in Omega Healthcare Investors by 86.1% during the third quarter. Smithfield Trust Co now owns 1,396 shares of the real estate investment trust’s stock valued at $58,000 after purchasing an additional 646 shares during the last quarter. Cypress Capital Group purchased a new stake in Omega Healthcare Investors during the third quarter valued at about $225,000. Advisors Asset Management Inc. lifted its holdings in Omega Healthcare Investors by 2.6% during the third quarter. Advisors Asset Management Inc. now owns 118,273 shares of the real estate investment trust’s stock valued at $4,814,000 after purchasing an additional 3,041 shares during the last quarter. Finally, Pathstone Holdings LLC lifted its holdings in Omega Healthcare Investors by 23.9% during the third quarter. Pathstone Holdings LLC now owns 32,112 shares of the real estate investment trust’s stock valued at $1,307,000 after purchasing an additional 6,199 shares during the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on OHI shares. Scotiabank upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Finally, Truist Financial increased their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors presently has a consensus rating of “Hold” and an average target price of $40.00.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Stock Down 0.2 %

Shares of NYSE OHI opened at $40.68 on Thursday. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm’s 50 day simple moving average is $40.60 and its two-hundred day simple moving average is $37.21. The stock has a market capitalization of $10.98 billion, a P/E ratio of 29.91, a PEG ratio of 1.25 and a beta of 0.99.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.59%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is currently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.